Cart
sales@molnova.com
CpCDPK1/TgCDPK1-IN-1
CAS No. 1092788-23-2
CpCDPK1/TgCDPK1-IN-1( —— )
Catalog No. M37202 CAS No. 1092788-23-2
CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infections and cryptosporidiosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 645 | In Stock |
|
| 10MG | 772 | In Stock |
|
| 25MG | 969 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCpCDPK1/TgCDPK1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infections and cryptosporidiosis.
-
DescriptionCpCDPK1/TgCDPK1-IN-1 (compound 7p) is a potent CpCDPK1/TgCDPK1 dual inhibitor (IC50: 10 nM and 5.0 nM respectively). CpCDPK1/TgCDPK1-IN-1 also inhibits Abl and Src (IC50: 75 nM and 65 nM respectively). CpCDPK1/TgCDPK1-IN-1 can be used for research of toxoplasmosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetSrc
-
RecptorSrc | Bcr-Abl
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1092788-23-2
-
Formula Weight303.36
-
Molecular FormulaC18H17N5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=1C=NC2=C(C1N)C(=NN2C(C)C)C=3C=CC=4C=CC=CC4C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wesley C. Van Voorhis, et al. Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases. Patent. US20130018040.
molnova catalog
related products
-
AP23846
AP23846 is a novel and potent Src family kinase inhibitor that reduces vascular endothelial growth factor and interleukin-8 expression and abrogates downstream angiogenic processes in human solid tumor cell lines.
-
Saracatinib
A potent, highly selective, orally available, dual Src/Abl kinase inhibitor with IC50 of 2.7, 4, 4 and 30 nM for c-Src, Yes, Lck and Abl, respectively.
-
CH6953755
CH6953755 is an orally active, potent and selective YES1 kinase inhibitor (IC50:1.8 nM).CH6953755 has anticancer activity and inhibits cancer cell proliferation by inhibiting YES1 kinase.
